Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Conditions

• Metastatic Small Intestinal Adenocarcinoma
• Recurrent Small Intestinal Carcinoma
• Unresectable Small Intestinal Carcinoma

Interventions

• OTHER: Laboratory Biomarker Analysis
• BIOLOGICAL: Pembrolizumab

Sponsor

Academic and Community Cancer Research United

Collaborators

• [object Object]